Analyst Ratings for Cidara Therapeutics (CDTX)

CDTX Rating Summary

CDTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CDTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.50 (+280.1%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/4/2021 Aegis Capital Nathan Weinstein New Coverage Buy
(N/A)
9.00
(N/A)
2.23
(1.71)
-23.32% Details
3/10/2020 Maxim Group Jason McCarthy New Coverage Buy
(N/A)
10.00
(N/A)
2.65
(1.71)
-35.47% Details
Like CDTX Ratings? Also take a look at SCYX, MLNT, NBRV, PRTK

CDTX Ratings News